CIK 0001855175 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Contineum Therapeutics, Inc.
Sign in to watch- Ticker
- CTNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271467257
- Phone
- (858) 333-5280
- Business address
- 3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,142
- in 1 filing, $41K under 10b5-1 plans
Net −$41,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion | +148,312 | 148,312 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series A Preferred Stock | +298,975 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series A Preferred Stock | +1,931 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B Preferred Stock | +70,498 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B Preferred Stock | +455 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B Preferred Stock | +90,747 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series C Preferred Stock | +22,312 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series C Preferred Stock | +145 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series C Preferred Stock | +57,565 | 0 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series A Preferred Stock | +1,476,446 | 1,476,446 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series A Preferred Stock | +9,252 | 9,252 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series A-1 Preferred Stock | +1,423,119 | 1,423,119 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B Preferred Stock | +348,143 | 1,824,589 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B Preferred Stock | +2,182 | 11,434 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B Preferred Stock | +434,725 | 434,725 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series B Preferred Stock | +317,988 | 1,741,107 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series C Preferred Stock | +110,187 | 1,934,776 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series C Preferred Stock | +689 | 12,123 | ||
| 2024-04-09 | Versant Venture Capital VI, L.P. 10% owner | Conversion · Series C Preferred Stock | +275,769 | 710,494 |
Page 7 of 7 · 139 trades